APA

Wagner K. W., Punnoose E. A., Januario T., Lawrence D. A., Pitti R. M., Lancaster K., Lee D., von Goetz M., Yee S. F., Totpal K., Huw L., Katta V., Cavet G., Hymowitz S. G., Amler L. & Ashkenazi A. (20080312). Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. : Nature medicine.

Chicago

Wagner Klaus W, Punnoose Elizabeth A, Januario Thomas, Lawrence David A, Pitti Robert M, Lancaster Kate, Lee Dori, von Goetz Melissa, Yee Sharon Fong, Totpal Klara, Huw Ling, Katta Viswanatham, Cavet Guy, Hymowitz Sarah G, Amler Lukas and Ashkenazi Avi. 20080312. Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. : Nature medicine.

Harvard

Wagner K. W., Punnoose E. A., Januario T., Lawrence D. A., Pitti R. M., Lancaster K., Lee D., von Goetz M., Yee S. F., Totpal K., Huw L., Katta V., Cavet G., Hymowitz S. G., Amler L. and Ashkenazi A. (20080312). Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. : Nature medicine.

MLA

Wagner Klaus W, Punnoose Elizabeth A, Januario Thomas, Lawrence David A, Pitti Robert M, Lancaster Kate, Lee Dori, von Goetz Melissa, Yee Sharon Fong, Totpal Klara, Huw Ling, Katta Viswanatham, Cavet Guy, Hymowitz Sarah G, Amler Lukas and Ashkenazi Avi. Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. : Nature medicine. 20080312.